Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions.
第一作者:
Robert A,Heald
第一单位:
Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, UK. robert.heald@glpg.com
作者:
医学主题词
别构调节(Allosteric Regulation);动物(Animals);抗肿瘤药(Antineoplastic Agents);苯呋喃类(Benzofurans);苯并噻唑类(Benzothiazoles);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);结晶学, X线(Crystallography, X-Ray);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);氢键合(Hydrogen Bonding);吲唑类(Indazoles);MAP激酶激酶1(MAP Kinase Kinase 1);MAP激酶激酶2(MAP Kinase Kinase 2);小鼠(Mice);模型, 分子(Models, Molecular);分子结构(Molecular Structure);肿瘤移植(Neoplasm Transplantation);大鼠(Rats);丝氨酸(Serine);构效关系(Structure-Activity Relationship);移植, 异种(Transplantation, Heterologous)
DOI
10.1021/jm2017094
PMID
22506516
发布时间
2013-11-21
- 浏览3
Journal of medicinal chemistry
4594-604页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



